Sold out yesterday for what its worth. Will take up full allocation of rights and try for the extra 25%. I don't like my chances on the extra 25%. Good luck to holders.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%